COMMUNIQUÉS West-GlobeNewswire
-
BioPorto announces Interim Result for the First Quarter of 2026
21/05/2026 -
Nanobiotix Announces Temporary Trading Halt of Its Ordinary Shares on Euronext Paris
21/05/2026 -
Nanobiotix annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris
21/05/2026 -
Orion Pharma to present its first clinical data from Phase 1/2 TEADES trial of TEAD inhibitor ODM-212 at the 2026 ASCO® Annual Meeting
21/05/2026 -
Déclaration Intermédiaire Premier Trimestre 2026: un début d’année sur la bonne voie, avec des avancées en matière d’innovation produits
21/05/2026 -
First quarter 2026 update: starting the year on track, with product innovation progress
21/05/2026 -
Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA
21/05/2026 -
Sifts Microplastic Binding Supplement Claims Evaluated: The Chitosan Fiber Formula for Daily Microplastic Particle Exposure Support
21/05/2026 -
Relay Therapeutics Announces Pricing of Public Offering of Common Stock
21/05/2026 -
NeuroZen Under Investigation - Critical Assessment Reveals Shocking Consumer Report Details Disclosed
21/05/2026 -
Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum
20/05/2026 -
Nanobiotix annonce le lancement d’une offre globale
21/05/2026 -
Informations sur le nombre total de droits de vote et d'actions
20/05/2026 -
Dentsply Sirona to Participate in the 2026 Stifel Jaws & Paws Conference
20/05/2026 -
Information on the total number of voting rights and shares
20/05/2026 -
L’Assemblée Générale Mixte de Cellectis se tiendra le le 25 juin 2026
20/05/2026 -
CVRx to Present at the William Blair 46th Annual Growth Stock Conference
20/05/2026 -
Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference
20/05/2026 -
Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update
20/05/2026
Pages